I received my Ph.D. degree in Biochemistry and Molecular biology from Shanghai Institute for Biological Sciences, Chinese Academy of Sciences in China. During my Ph.D., I worked on the function and mechanism of transcriptional coactivator, Mediator complex. I was interested in one of its subunits from tail module, Mediator MED23, and studied its function in mammalian pigmentation and DNA damage response and repair. After graduation in 2016, I joined Dr. Ari Melnick’s lab to study the development and targeted therapy of B-cell lymphoma. My current work is to understand the underling mechanism of gene mutations that affected important signaling pathways in DLBCL, thus to provide therapeutic targets for lymphoma treatment.